Seth Klarman Theravance Biopharma, Inc. Transaction History

Baupost Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$8.29 - $9.92 $19.8 Million - $23.7 Million	-2,394,105 Reduced 36.31%	4,200,021 $35.6 Million
Q1 2024 May 14, 2024	SELL	$8.22 - $11.59 $6.78 Million - $9.56 Million	-825,100 Reduced 11.12%	6,594,126 $59.1 Million
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $30.5 Million - $35.8 Million	-3,000,000 Reduced 28.79%	7,419,226 $76.8 Million
Q1 2023 May 12, 2023	SELL	$9.87 - $11.44 $9.87 Million - $11.4 Million	-1,000,000 Reduced 8.76%	10,419,226 $113 Million
Q4 2022 Feb 13, 2023	SELL	$9.65 - $11.34 $19.3 Million - $22.7 Million	-2,000,000 Reduced 14.9%	11,419,226 $128 Million
Q2 2022 Aug 12, 2022	SELL	$8.41 - $10.34 $1.88 Million - $2.32 Million	-224,107 Reduced 1.64%	13,419,226 $122 Million
Q1 2022 May 13, 2022	SELL	$8.33 - $12.96 $140,235 - $218,181	-16,835 Reduced 0.12%	13,643,333 $130 Million
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $25.4 Million - $54 Million	3,750,000 Added 37.84%	13,660,168 $101 Million
Q2 2021 Aug 13, 2021	BUY	$14.52 - $22.46 $17.1 Million - $26.4 Million	1,175,000 Added 13.45%	9,910,168 $144 Million
Q3 2020 Nov 13, 2020	SELL	$14.79 - $22.49 $8.49 Million - $12.9 Million	-574,000 Reduced 6.17%	8,735,168 $129 Million
Q3 2017 Nov 13, 2017	BUY	$23.88 - $34.96 $222 Million - $325 Million	9,309,168	9,309,168 $319 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.